stoxline Quote Chart Rank Option Currency Glossary
  
Eucrates Biomedical Acquisition Corp. (EUCR)
10.04  0 (0%)    04-26 15:14
Open: 10.04
High: 10.04
Volume: 12,700
  
Pre. Close: 10.04
Low: 10.02
Market Cap: 42(M)
Technical analysis
2023-06-16 4:43:28 PM
Short term     
Mid term     
Targets 6-month :  11.79 1-year :  11.85
Resists First :  10.1 Second :  10.14
Pivot price 10.04
Supports First :  10.02 Second :  8.33
MAs MA(5) :  10.03 MA(20) :  10.05
MA(100) :  10.06 MA(250) :  9.98
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  32.5 D(3) :  24.5
RSI RSI(14): 33.6
52-week High :  10.25 Low :  9.86
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ EUCR ] has closed above bottom band by 43.2%. Bollinger Bands are 91.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 10.06 - 10.11 10.11 - 10.15
Low: 9.9 - 9.97 9.97 - 10.02
Close: 9.94 - 10.05 10.05 - 10.13
Company Description

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Headline News

Tue, 11 Apr 2023
Eucrates Biomedical Acquisition Corp. Announces Liquidation - PR Newswire

Tue, 27 Jul 2021
AdTheorent Going Public with MCAP Acquisition (MACQ) - TheStreet

Tue, 20 Jul 2021
CCIV Rises Ahead of Lucid Vote, Reminds to Vote - TheStreet

Fri, 25 Jun 2021
Churchill (CCIV) & Lucid Sets its Vote Date - TheStreet

Mon, 14 Dec 2020
Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable ... - BioSpace

Thu, 05 Nov 2020
SPACs Soar as Fast, Hassle-Free IPO Alternatives for Biotech Companies - BioSpace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Financial Services
Industry:
Shell Companies
Shares Out 4 (M)
Shares Float 2 (M)
Held by Insiders 62.2 (%)
Held by Institutions 9.1 (%)
Shares Short 1 (K)
Shares Short P.Month 1 (K)
Stock Financials
EPS 0.2
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.88
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 22.7 %
Operating Cash Flow -1 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 47.8
PEG Ratio 0
Price to Book value -11.41
Price to Sales 0
Price to Cash Flow -67.07
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android